Deal

SantoSolve raises USD 5.5 million

The Norwegian biotech company SantoSolve has completed a new round of financing, and managed to raise USD 5.5 million.

Contributions have been made by existing investors Teknoinvest, Investinor and InnovationsKapital, and new investors include DnBNor, Gezina and Glastad Invest. The funding will enable further advancements in the development of SantoSolves lead product 2PX.

Read more


FundTeknoinvest VIII KS Argentum share 32.43%
Portfolio CompanySantoSolve
Date of Transaction2007-11-09
TransactionFinance round
Seller
BuyerTeknoinvest VIII KS
Size of TransactionUSD 5.5m
Ind. FocusLife Science
GeographyNorway
StageVenture
 

More Teknoinvest VIII KS or SantoSolve deals

More deals

(2011-07-13)